Hillard M Lazarus Selected Research

Autologous Transplantation

1/2022	Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.
1/2020	Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
1/2019	Gastrointestinal Microbiome and Mycobiome Changes during Autologous Transplantation for Multiple Myeloma: Results of a Prospective Pilot Study.
1/2019	Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma.
1/2018	Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
1/2018	Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma.
11/2015	Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
4/2015	New cancers after autotransplantations for multiple myeloma.
2/2015	Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma.
11/2014	Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hillard M Lazarus Research Topics

Disease

55	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 07/2003
53	Neoplasms (Cancer) 01/2022 - 01/2002
35	Leukemia 01/2022 - 02/2002
29	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 02/2004
26	Multiple Myeloma 01/2022 - 02/2006
26	Lymphoma (Lymphomas) 01/2020 - 07/2002
24	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 10/2003
22	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 01/2003
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 07/2003
19	Infections 01/2022 - 01/2002
18	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 04/2002
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 08/2009
10	Bronchiolitis Obliterans Syndrome 01/2021 - 07/2010
9	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 11/2003
7	Pathologic Complete Response 01/2020 - 01/2007
6	Obesity 01/2022 - 05/2006
6	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 07/2005
6	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2002
5	Pain (Aches) 01/2020 - 06/2004
5	Philadelphia Chromosome 11/2016 - 05/2009
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2016 - 02/2006
5	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 03/2003
4	Mycoses (Diseases, Fungus) 01/2021 - 01/2002
4	Overweight 01/2020 - 05/2006
4	Fever (Fevers) 01/2019 - 01/2002
3	COVID-19 10/2022 - 01/2021
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2022 - 02/2006
3	Immunoglobulin Light-chain Amyloidosis 01/2022 - 06/2008
3	Plasma Cell Leukemia 07/2021 - 12/2020
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 09/2012
3	Neutropenia 01/2021 - 01/2002
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2012
3	Body Weight (Weight, Body) 01/2020 - 07/2002
3	Thrombotic Microangiopathies 01/2020 - 01/2009
3	Aplastic Anemia (Anemia, Hypoplastic) 10/2019 - 02/2011
3	Nausea 01/2019 - 05/2003
3	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2009
3	Vomiting 01/2019 - 05/2003
3	Diarrhea 01/2018 - 05/2003
3	Multiple Sclerosis 01/2018 - 05/2012
3	Monoclonal Gammopathy of Undetermined Significance 09/2015 - 06/2008
3	Hematologic Diseases (Blood Diseases) 07/2015 - 01/2011
3	Invasive Fungal Infections 09/2010 - 01/2002
3	Iron Overload 06/2010 - 07/2008
3	Disease Progression 03/2010 - 03/2003
2	Pneumonia (Pneumonitis) 01/2022 - 11/2015
2	Virus Diseases (Viral Diseases) 12/2021 - 01/2021
2	Amyloidosis 01/2021 - 11/2015
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

15	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 07/2003
12	Rituximab (Mabthera)FDA Link 01/2020 - 01/2006
8	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 07/2011
7	fludarabineIBA 11/2021 - 10/2004
6	Biological ProductsIBA 01/2021 - 09/2014
6	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2005
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2021 - 01/2013
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2021 - 07/2015
5	AnthracyclinesIBA 01/2019 - 09/2009
5	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2006
4	Calcineurin InhibitorsIBA 01/2022 - 02/2016
4	Busulfan (Busulfex)FDA Link 11/2021 - 01/2018
4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2009
4	Bortezomib (Velcade)FDA Link 01/2021 - 01/2009
4	VaccinesIBA 01/2021 - 11/2012
4	AntigensIBA 01/2021 - 02/2004
4	midostaurinIBA 01/2020 - 07/2015
4	Carmustine (FIVB)FDA Link 01/2019 - 01/2005
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2019 - 11/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	Voriconazole (Vfend)FDA LinkGeneric 01/2021 - 01/2002
3	Monoclonal AntibodiesIBA 01/2021 - 11/2009
3	Thalidomide (Thalomid)FDA Link 01/2020 - 01/2009
3	Pharmaceutical PreparationsIBA 12/2019 - 05/2003
3	Chimeric Antigen ReceptorsIBA 12/2019 - 01/2018
3	Azacitidine (5 Azacytidine)FDA Link 01/2019 - 07/2015
3	Lenalidomide (CC 5013)FDA Link 10/2011 - 06/2008
2	LithiumIBA 01/2022 - 01/2020
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2021 - 02/2004
2	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2021 - 01/2002
2	sargramostim (Leukine)FDA Link 01/2021 - 01/2021
2	Itraconazole (Sporanox)FDA LinkGeneric 01/2021 - 05/2003
2	Alemtuzumab (Campath)FDA Link 01/2020 - 03/2016
2	AlbuminsIBA 01/2020 - 11/2016
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2012
2	Immunomodulating AgentsIBA 01/2020 - 01/2018

Therapy/Procedure

115	Cell Transplantation 11/2022 - 01/2006
73	Therapeutics 01/2022 - 01/2002
61	Transplantation 04/2022 - 04/2003
42	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
36	Hematopoietic Stem Cell Transplantation 10/2022 - 01/2002
25	Homologous Transplantation 11/2021 - 04/2006
24	Autologous Transplantation 01/2022 - 03/2003
18	Stem Cell Transplantation 01/2021 - 01/2002
7	Induction Chemotherapy 01/2021 - 01/2005
6	Immunotherapy 01/2021 - 11/2012
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2019 - 07/2002
4	Blood Component Removal (Apheresis) 01/2020 - 11/2013
3	Haploidentical Transplantation 01/2022 - 01/2016
2	Donor Selection 03/2022 - 01/2016